The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study.
paper
Cited
Public
Unavailable
- Authors
- Degenhardt, Louisa; Charlson, Fiona; Mathers, Bradley; Hall, Wayne D; Flaxman, Abraham D; Johns, Nicole; Vos, Theo
- Year
- 2014
- Journal
- Addiction (Abingdon, England)
- PMID
- 24661272
- DOI
- 10.1111/add.12551
AIMS: To estimate the prevalence and burden of disease attributable to opioid dependence globally, regionally and at country level. METHODS: Multiple search strategies: (i) peer-reviewed literature searches; (ii) systematic searches of online databases; (iii) internet searches; (iv) consultation and feedback from experts. Culling and data extraction followed protocols. DisMod-MR, the latest version of the generic disease modelling system, a Bayesian meta-regression tool, imputed prevalence by age, year and sex for 187 countries and 21 regions. Disability weight for opioid dependence was estimated through population surveys and multiplied by prevalence data to calculate the years of life lived with disability (YLDs). Opioid dependence premature mortality was computed as years of life lost (YLLs) and summed with YLDs to calculate disability-adjusted life years (DALYs). RESULTS: There were 15.5 million opioid-dependent people globally in 2010 [0.22%, 95% uncertainty interval (UI) = 0.20-0.25%]. Age-standardized prevalence was higher in males (0.30%, 95% UI = 0.27-0.35%) than females (0.14%, 95% UI = 0.12-0.16%), and peaked at 25-29 years. Prevalence was higher than the global pooled prevalence in Australasia (0.46%, 95% UI = 0.41-0.53%), western Europe (0.35%, 95% UI = 0.32-0.39) and North America (0.30%, 95% UI = 0.25-0.36). Opioid dependence was estimated to account for 9.2 million DALYs globally (0.37% of global DALYs) in 2010, a 73% increase on DALYs estimated in 1990. Regions with the highest opioid dependence DALY rates were North America (292.1 per 100,000), eastern Europe (288.4 per 100,000), Australasia (278.6 per 100,000) and southern sub-Saharan Africa (263.5 per 100,000). The contribution of YLLs to opioid dependence burden was particularly high in North America, eastern Europe and southern sub-Saharan Africa. CONCLUSION: Opioid dependence is a substantial contributor to the global disease burden; its contribution to premature mortality (relative to prevalence) varies geographically, with North America, eastern Europe and southern sub-Saharan Africa most strongly affected.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Cis-Expression Quantitative Trait Loci Mapping Reveals Replicable Associations with Heroin Addiction in OPRM1. | 2015 | 25744370 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Opioid Use Following Spine Surgery: Strategies for a Multimodal Approach To Pain Management. | Erbeldinger L et al. | — | 2026 | → |
| A randomized, sham-controlled clinical trial to evaluate the NET Device™ for reducing withdrawal symptom severity during opioid discontinuation. | Greenwald MK et al. | — | 2025 | → |
| Burden of opioid use disorder in the Middle East and North Africa (MENA): findings from Global Burden of Disease (GBD) study. | Effatpanah M et al. | — | 2025 | → |
| Burden of Substance Use Disorders in the Middle East and North Africa from 1990 to 2019. | Darijani SR et al. | — | 2025 | → |
| Direct analysis in real time mass spectrometry (DART-MS/MS) for rapid urine opioid detection in a clinical setting. | Choucair I et al. | — | 2025 | → |
| Global, regional, and national trends and burden of opioid use disorder in individuals aged 15 years and above: 1990 to 2021 and projections to 2040. | Wang S et al. | — | 2025 | → |
| Investigating outcomes in a substance use treatment provider: a cross-sectional comparison of long-acting injectable buprenorphine and oral medication for opioid use disorder. | Montgomery C et al. | — | 2025 | → |
| Left ventromedial prefrontal cortex inhibitory rTMS as an anti-stress intervention in opioid use disorder: Trial design. | Moses TE et al. | — | 2025 | → |
| Methadone and the Kidney: Dissecting Gender Differences in Inflammation and Oxidative Stress Responses. | Kosari K et al. | — | 2025 | → |
| Multimethod feasibility evaluation of smoking cessation intervention for patients receiving opioid agonist therapy. | Druckrey-Fiskaaen KT et al. | — | 2025 | → |
| Post-discharge use of opioids, psychostimulants, and treatment medications following residential opioid discontinuation with NET Device™ monotherapy. | Greenwald MK et al. | — | 2025 | → |
| Reconstructing Cross-Cultural Meanings of Addiction Among Women from Three Countries. | Placek CD et al. | — | 2025 | → |
| Validity, reliability and clinical utility of ASSIST-Y in assessing risk of substance-related harm and dependence in Spanish male adolescents. | Ibáñez-Martínez N et al. | — | 2025 | → |
| Valvular dysfunction and cardiovascular risk in individuals with opioid use disorder who are maintained on buprenorphine/naloxone: a focus on pan-immune-inflammation value and uric acid-to-albumin ratio. | Eyiol H et al. | — | 2025 | → |
| Association of KRAS and TERT Genetic Variants with Opioid Dependence in a Large Clinical Cohort | Cuomo RE | — | 2024 | — |
| Caregivers' Attitudes Toward Treatment Length for Persons in Swedish Opioid Agonist Treatment. A Qualitative Interview Study. | Nehlin C et al. | — | 2024 | → |
| Cytokines in hepatitis C-infected patients with or without opioid maintenance therapy. | Nygaard-Odeh K et al. | — | 2024 | → |
| Intrinsic anti-inflammatory nanomedicines for enhanced pain management. | Qiao B et al. | — | 2024 | → |
| Nationally Representative Rates of Incident Prescription Opioid Use Among United States Adults and Selected Subpopulations: Longitudinal Cohort Study From the National Health Interview Survey, 2019 to 2020. | D'Souza RS et al. | — | 2024 | → |
| Opioid use following cardio-thoracic intensive care: risk factors and outcomes: a cohort study. | von Oelreich E et al. | — | 2024 | → |
| Prevalence of substance use disorder diagnoses in patients with chronic pain receiving reimbursed opioids: An epidemiological study of four Norwegian health registries. | Nøst TH et al. | — | 2024 | → |
| Risk Factors for Opioid Misuse, Abuse, and Dependence Among Pain Clinic Patients: A Cross-Sectional Study at King Khalid University Hospital during 2020. | Alamro NM et al. | — | 2024 | → |
| Strategies for improving treatment retention for buprenorphine/naloxone for opioid use disorder: a qualitative study of issues and recommendations from prescribers. | Young GJ et al. | — | 2024 | → |
| A Guide to Expanding the Use of Buprenorphine Beyond Standard Initiations for Opioid Use Disorder. | Miller JC et al. | — | 2023 | → |
| A qualitative study on people with opioid use disorders' perspectives on smoking and smoking cessation interventions. | Druckrey-Fiskaaen KT et al. | — | 2023 | → |
| Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A Review. | Kiluk BD et al. | — | 2023 | → |
| Experiences and Outcomes of Using e-Prescribing for Opioids: Rapid Scoping Review. | Guilcher SJT et al. | — | 2023 | → |
| Nociceptin Receptor-Related Agonists as Safe and Non-addictive Analgesics. | Ding H et al. | — | 2023 | → |
| Patterns and Predictors of Heroin Use, Remission, and Psychiatric Health Among People with Heroin Dependence: Key Findings from the 18-20-Year Follow-Up of the Australian Treatment Outcome Study (ATOS). | Marel C et al. | — | 2023 | → |
| The effects of childhood trauma and mental disorders on treatment engagement, contact with the criminal justice system, and mortality among people with opioid dependence. | Santo T et al. | — | 2023 | → |
| The Spanish language version of the TAPS tool: protocol for a validation and implementation study in primary care. | Gryczynski J et al. | — | 2023 | → |
| A randomized, sham-controlled, quintuple-blinded trial to evaluate the NET device as an alternative to medication for promoting opioid abstinence. | Greenwald MK et al. | — | 2022 | → |
| A rural community's perspective on the causes of and solutions to the opioid crisis in southern Virginia: a qualitative study. | Hargrove AJ et al. | — | 2022 | → |
| A systematic review of assessment approaches to predict opioid misuse in people with cancer. | Keall R et al. | — | 2022 | → |
| Cannabinoids and Their Role in Chronic Pain Treatment: Current Concepts and a Comprehensive Review. | Shehata I et al. | — | 2022 | → |
| Community-based naloxone coverage equity for the prevention of opioid overdose fatalities in racial/ethnic minority communities in Massachusetts and Rhode Island. | Nolen S et al. | — | 2022 | → |
| Diagnosis and treatment of opioid-related disorders in a South African private sector medical insurance scheme: A cohort study. | Tlali M et al. | — | 2022 | → |
| Evaluation of Opioid Prescribing Patterns and Use Following Hysterectomy for Benign Indication: A Prospective Cohort Study. | Nwosu I et al. | — | 2022 | → |
| Long-term opioid use and mortality in patients with chronic non-cancer pain: Ten-year follow-up study in South Korea from 2010 through 2019. | Song IA et al. | — | 2022 | → |
| Long-term patient outcomes following buprenorphine/naloxone treatment for opioid use disorder: a retrospective analysis in a commercially insured population. | Hasan MM et al. | — | 2022 | → |
| Patients' Perspectives on Coming Off Opioid Agonist Treatment: A Qualitative Study. | Nehlin C et al. | — | 2022 | → |
| Perceptions and experiences of patients attending an opioid substitution clinic in South Africa. | Domingo AK et al. | — | 2022 | → |
| Polysubstance Use, Mood Disorders, and Chronic Conditions With Anxiety in Opioid Patients. | Liu S et al. | — | 2022 | → |
| Potential therapeutic targets for the treatment of opioid abuse and pain. | Kiguchi N et al. | — | 2022 | → |
| Preoperative Opioid Dose and Surgical Outcomes in Colorectal Surgery. | Lo BD et al. | — | 2022 | → |
| Spouse and Child Abuse Associated With Illicit Drug Use in Iran: A Systematic Review and Meta-Analysis. | Baheshmat S et al. | — | 2022 | → |
| The impact of an easy access drug supply management policy law on the consumption and abuse of opioids in Catalonia: A population-based study. | Carrilero N et al. | — | 2022 | → |
| Therapeutic potentials of NOP and MOP receptor coactivation for the treatment of pain and opioid abuse. | Kiguchi N et al. | — | 2022 | → |
| The Role of Glia in Addiction: Dopamine as a Modulator of Glial Responses in Addiction. | Jiménez-González A et al. | — | 2022 | → |
| The Status and Prescription Patterns of Opioid Utilization in a Large Comprehensive Teaching Hospital in China According to the Anatomical Therapeutic Chemical Classification/Defined Daily Dose Methodology. | Fang T et al. | — | 2022 | → |
| Urinalysis based assessment of compliance and drug use patterns in patients prescribed tramadol: A cross-sectional study from a tertiary care centre. | Jain R et al. | — | 2022 | → |
| Use and misuse of opioid after gynecologic surgery. | Bougie O et al. | — | 2022 | → |
| Association of prescription opioid use on mortality and hospital length of stay in the intensive care unit. | Hardy N et al. | — | 2021 | → |
| Correlates of Non-fatal, Opioid Overdose among Women Who Use Opioids in Dar es Salaam, Tanzania. | Saleem HT et al. | — | 2021 | → |
| Development and Feasibility of a Spanish Language Version of the Tobacco, Alcohol, Prescription Drug, and Illicit Substance Use (TAPS) Tool. | Sanchez K et al. | — | 2021 | → |
| Electroencephalography-based cortical sources of working memory in the subjects with opioid addiction: A pilot study. | Sadananda S et al. | — | 2021 | → |
| Enhanced recovery strategies after penile implantation: a narrative review. | Ellis JL et al. | — | 2021 | → |
| Evaluation of functional status among patients undergoing maintenance treatments for opioid use disorders. | Ruíz Ruíz JJ et al. | — | 2021 | → |
| Evolution of doctor shopping for oxycodone in the 67 million inhabitants in France as a proxy for potential misuse or abuse. | Soeiro T et al. | — | 2021 | → |
| Factors Associated with Low Bone Density in Opioid Substitution Therapy Patients: A Systematic Review. | Ramli FF et al. | — | 2021 | → |
| Feasibility and acceptability of using smartphone-based EMA to assess patterns of prescription opioid and medical cannabis use among individuals with chronic pain. | Anderson Goodell EM et al. | — | 2021 | → |
| Feasibility of Intranasal Dexmedetomidine in Treatment of Postoperative Restlessness, Agitation, and Pain in Geriatric Orthopedic Patients. | Uusalo P et al. | — | 2021 | → |
| Impact of Chronic Alcohol and Opioid Dependence on Biochemical Parameters: A Retrospective Case Control Study from a Tertiary Care Treatment Center in North India. | Quraishi R et al. | — | 2021 | → |
| Implementation facilitation to introduce and support emergency department-initiated buprenorphine for opioid use disorder in high need, low resource settings: protocol for multi-site implementation-feasibility study. | McCormack RP et al. | — | 2021 | → |
| Intranasal Dexmedetomidine Reduces Postoperative Opioid Requirement in Patients Undergoing Total Knee Arthroplasty Under General Anesthesia. | Seppänen SM et al. | — | 2021 | → |
| Long term pre-treatment opioid use trajectories in relation to opioid agonist therapy outcomes among people who use drugs in a Canadian setting. | Dong H et al. | — | 2021 | → |
| Municipal police support for harm reduction services in officer-led referrals of people who inject drugs in Tijuana, Mexico. | Baker P et al. | — | 2021 | → |
| Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapse. | Greiner MG et al. | — | 2021 | → |
| Novel Long-Acting Buprenorphine Medications for Opioid Dependence: Current Update. | Soyka M | — | 2021 | → |
| Pharmacotherapies for the Treatment of Alcohol Use Disorders During Pregnancy: Time to Reconsider? | Kelty E et al. | — | 2021 | → |
| Plasma concentrations of granulocyte colony-stimulating factor (G-CSF) in patients with substance use disorders and comorbid major depressive disorder. | Galván ST et al. | — | 2021 | → |
| Recent advances in the treatment of opioid use disorders-focus on long-acting buprenorphine formulations. | Soyka M et al. | — | 2021 | → |
| Risk and protective factors for cannabis, cocaine, and opioid use disorders: An umbrella review of meta-analyses of observational studies. | Solmi M et al. | — | 2021 | → |
| Sex differences in factors predicting post-treatment opioid use. | Davis JP et al. | — | 2021 | → |
| Take-home naloxone programs for suspected opioid overdose in community settings: a scoping umbrella review. | Moustaqim-Barrette A et al. | — | 2021 | → |
| The Effect of Stress Management Techniques on Persons with Addictive Behaviors: a Systematic Review. | Louvardi M et al. | — | 2021 | → |
| The impact of the opioid crisis on U.S. state prison systems. | Scott CK et al. | — | 2021 | → |
| The Role of Mu-Opioids for Reward and Threat Processing in Humans: Bridging the Gap from Preclinical to Clinical Opioid Drug Studies. | Meier IM et al. | — | 2021 | → |
| Transition From Full Mu Opioid Agonists to Buprenorphine in Opioid Dependent Patients-A Critical Review. | Soyka M | — | 2021 | → |
| Translational value of non-human primates in opioid research. | Ding H et al. | — | 2021 | → |
| What Are the Correlates of Global Variations in the Prevalence of Opioid Use Disorders? An Analysis of Data From the Global Burden of Disease Study, 2019. | Rajkumar RP | — | 2021 | → |
| 3D printed opioid medicines with alcohol-resistant and abuse-deterrent properties. | Ong JJ et al. | — | 2020 | → |
| Anxiety sensitivity and opioid misuse and dependence among trauma-exposed adults with chronic pain. | Zvolensky MJ et al. | — | 2020 | → |
| Australian treatment outcome study: protocol for the 18-20-year follow-up of a prospective longitudinal cohort examining the natural history of heroin dependence and associated mortality, psychiatric and physical health, and health service use. | Marel C et al. | — | 2020 | → |
| Brief Training on Medication-Assisted Treatment Improves Community Mental Health Clinicians' Confidence and Readiness to Address Substance Use Disorders. | Iheanacho T et al. | — | 2020 | → |
| Buprenorphine to reverse respiratory depression from methadone overdose in opioid-dependent patients: a prospective randomized trial. | Zamani N et al. | — | 2020 | → |
| Characteristics Associated with Nonmedical Methadone Use among People Who Inject Drugs in California. | Zhao JK et al. | — | 2020 | → |
| Chronic Non-Malignant Pain in Patients with Cancer Seen at a Timely Outpatient Palliative Care Clinic. | Hui D et al. | — | 2020 | → |
| Chronic Opioid Use and Risk of Cancer in Patients with Chronic Noncancer Pain: A Nationwide Historical Cohort Study. | Oh TK et al. | — | 2020 | → |
| Dihydrocodeine for detoxification and maintenance treatment in individuals with opiate use disorders. | Carney T et al. | — | 2020 | → |
| Emotion regulation and motives for illicit drug use in opioid-dependent patients. | Gold AK et al. | — | 2020 | → |
| Examining correlations between opioid dispensing and opioid-related hospitalizations in Canada, 2007-2016. | Jones W et al. | — | 2020 | → |
| Exposure to Medicines in the Family Medicine Cabinet: Is It a Harbinger of Later Opioid Dependence? | Elliott AL et al. | — | 2020 | → |
| GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents. | Yosten GL et al. | — | 2020 | → |
| <i>ALDH2</i> Gene: Its Effects on the Neuropsychological Functions in Patients with Opioid Use Disorder Undergoing Methadone Maintenance Treatment. | Lee PW et al. | — | 2020 | → |
| Modulation of object memory consolidation by heroin and heroin-conditioned stimuli: Role of opioid and noradrenergic systems. | Wolter M et al. | — | 2020 | → |
| Nociceptin/Orphanin FQ Peptide Receptor-Related Ligands as Novel Analgesics. | Kiguchi N et al. | — | 2020 | → |
| One-Year Mortality After Emergency Department Visit for Nonfatal Opioid Poisoning: A Population-Based Analysis. | Leece P et al. | — | 2020 | → |
| Opioid withdrawal and memory consolidation. | Baidoo N et al. | — | 2020 | → |
| Overcoming Heroin Addiction without the Use of Pharmaceuticals: A Qualitative Interview Study. | Nehlin C et al. | — | 2020 | → |
| Policing Practices and Risk of HIV Infection Among People Who Inject Drugs. | Baker P et al. | — | 2020 | → |
| Prenatal drug exposure and neurodevelopmental programming of glucocorticoid signalling. | Franks AL et al. | — | 2020 | → |
| Stratified analyses of genome wide association study data reveal haplotypes for a candidate gene on chromosome 2 (KIAA1211L) is associated with opioid use in patients of Arabian descent. | Alblooshi H et al. | — | 2020 | → |
| Systematic benefit-risk assessment for buprenorphine implant: a semiquantitative method to support risk management. | Osborne V et al. | — | 2020 | → |
| The evolution of opioid-related mortality and potential years of life lost in Spain from 2008 to 2017: differences between Spain and the United States. | Salazar A et al. | — | 2020 | → |
| The impact of psychiatric comorbidity on treatment discontinuation among individuals receiving medications for opioid use disorder. | Friesen EL et al. | — | 2020 | → |
| Training and transfer effects of working memory training in male abstinent long-term heroin users. | Zhao X et al. | — | 2020 | → |
| Tramadol for the Management of Opioid Withdrawal: A Systematic Review of Randomized Clinical Trials. | Shah K et al. | — | 2020 | → |
| Years of Life Lost due to Opioid Overdose in Ohio: Temporal and Geographic Patterns of Excess Mortality. | Hall OT et al. | — | 2020 | → |
| "Abusing Addiction": Our Language Still Isn't Good Enough. | Ashford RD et al. | — | 2019 | → |
| At-a-glance - The local response to the Canadian opioid epidemic in the Kingston, Frontenac, and Lennox and Addington communities. | Bahji A et al. | — | 2019 | → |
| Balancing opioid analgesia with the risk of nonmedical opioid use in patients with cancer. | Arthur J et al. | — | 2019 | → |
| BU10038 as a safe opioid analgesic with fewer side-effects after systemic and intrathecal administration in primates. | Kiguchi N et al. | — | 2019 | → |
| Correlation between interleukin-6 levels and methadone maintenance therapy outcomes. | Lu RB et al. | — | 2019 | → |
| Differences in receipt of opioid agonist treatment and time to enter treatment for opioid use disorder among specialty addiction programs in the United States, 2014-17. | Yang JC et al. | — | 2019 | → |
| Effects of sedative drug use on the dopamine system: a systematic review and meta-analysis of in vivo neuroimaging studies. | Kamp F et al. | — | 2019 | → |
| Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. | Haight BR et al. | — | 2019 | → |
| Female-male differences in prescription pain reliever dependence levels: Evidence on newly incident adolescent and young adult users in the United States, 2002-2014. | Cheng HG et al. | — | 2019 | → |
| Implications of Chronic Opioid Therapy on Perioperative Complications and Long-Term Surgical Recovery. | Liu D et al. | — | 2019 | → |
| Mechanisms and Clinical Features of Co-occurring Opioid and Nicotine Use. | Lichenstein SD et al. | — | 2019 | → |
| Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic. | Irvine MA et al. | — | 2019 | → |
| Mortality Associated With Opioid Overdose: A Review of Clinical Characteristics and Health Services Received in the Year Prior to Death. | Rose C et al. | — | 2019 | → |
| Neonatal abstinence syndrome in countries with no to low medical opioid consumption: a scoping review. | Marcellus L | — | 2019 | → |
| [New slow-release buprenorphine formulations for optimization of opioid substitution]. | Soyka M et al. | — | 2019 | → |
| Opioid-prescribing Patterns for Pediatric Patients in the United States. | Groenewald CB | — | 2019 | → |
| Opioid Use Epidemic in Mexico: Global Solutions to a Global Problem. | Palinkas LA | — | 2019 | → |
| Physiological Response to Opioids. | Tyan P et al. | — | 2019 | → |
| Preadmission chronic opioid usage and its association with 90-day mortality in critically ill patients: a retrospective cohort study. | Oh TK et al. | — | 2019 | → |
| Precision public health: Mapping socioeconomic disparities in opioid dispensations at Swedish pharmacies by Multilevel Analysis of Individual Heterogeneity and Discriminatory Accuracy (MAIHDA). | Persmark A et al. | — | 2019 | → |
| Quality of primary care among individuals receiving treatment for opioid use disorder. | Spithoff S et al. | — | 2019 | → |
| Reduced volumes of the external and internal globus pallidus in male heroin addicts: a postmortem study. | Müller UJ et al. | — | 2019 | → |
| Reduction in mortality risk with opioid agonist therapy: a systematic review and meta-analysis. | Bahji A et al. | — | 2019 | → |
| Sexual Dysfunction and Quality of Life in Chronic Heroin-Dependent Individuals on Methadone Maintenance Treatment. | Llanes C et al. | — | 2019 | → |
| The brain-placental axis: Therapeutic and pharmacological relevancy to pregnancy. | Behura SK et al. | — | 2019 | → |
| 'Too little dose - too early discontinuation?'-Effect of buprenorphine dose on short term treatment adherence in opioid dependence. | Muruganandam P et al. | — | 2019 | → |
| Trends in chronic opioid use and association with five-year survival in South Korea: a population-based cohort study. | Oh TK et al. | — | 2019 | → |
| Using the theory of planned behavior to investigate community pharmacists' beliefs regarding engaging patients about prescription drug misuse. | Fleming ML et al. | — | 2019 | → |
| A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates. | Ding H et al. | — | 2018 | → |
| Addiction Biomarkers: Dimensional Approaches to Understanding Addiction. | Kwako LE et al. | — | 2018 | → |
| A Mixed-Method Analysis of Persisting Effects Associated with Positive Outcomes Following Ibogaine Detoxification. | Davis AK et al. | — | 2018 | → |
| A polymorphism in the OPRM1 3'-untranslated region is associated with methadone efficacy in treating opioid dependence. | Crist RC et al. | — | 2018 | → |
| Canadian trends in opioid-related mortality and disability from opioid use disorder from 1990 to 2014 through the lens of the Global Burden of Disease Study. | Orpana HM et al. | — | 2018 | → |
| Correlation of cytokines, BDNF levels, and memory function in patients with opioid use disorder undergoing methadone maintenance treatment. | Wang TY et al. | — | 2018 | → |
| Extended-release injectable naltrexone for opioid use disorder: a systematic review. | Jarvis BP et al. | — | 2018 | → |
| Factors affecting the dose of methadone among patients receiving methadone maintenance therapy in Taiwan. | Li DJ et al. | — | 2018 | → |
| High-intensity cannabis use is associated with retention in opioid agonist treatment: a longitudinal analysis. | Socías ME et al. | — | 2018 | → |
| 'I have it just in case' - Naloxone access and changes in opioid use behaviours. | Heavey SC et al. | — | 2018 | → |
| Improving wait time from referral to opiate replacement therapy in a drug recovery service. | Beattie M et al. | — | 2018 | → |
| Opioid misuse in gastroenterology and non-opioid management of abdominal pain. | Szigethy E et al. | — | 2018 | → |
| Predictors of transitions across stages of heroin use and dependence prior to treatment-seeking among people in treatment for opioid dependence. | Larance B et al. | — | 2018 | → |
| Preoperative Opioid Use is a Predictor of Poor Return to Work in Workers' Compensation Patients After Lumbar Diskectomy. | O'Donnell JA et al. | — | 2018 | → |
| Should Antibiotics Be Controlled Medicines? Lessons from the Controlled Drug Regimen. | Storehagen L et al. | — | 2018 | → |
| Supervised Injectable Opioid Treatment for the Management of Opioid Dependence. | Bell J et al. | — | 2018 | → |
| The Burden of Opioid-Related Mortality in the United States. | Gomes T et al. | — | 2018 | → |
| The Cholinergic System as a Treatment Target for Opioid Use Disorder. | Jensen KP et al. | — | 2018 | → |
| The Economic Burden of Abuse of Prescription Opioids: A Systematic Literature Review from 2012 to 2017. | Reinhart M et al. | — | 2018 | → |
| The risk for problematic opioid use in chronic pain: What can we learn from studies of pain and reward? | Finan PH et al. | — | 2018 | → |
| The Syndemic of Opioid Misuse, Overdose, HCV, and HIV: Structural-Level Causes and Interventions. | Perlman DC et al. | — | 2018 | → |
| Tramadol (opioid) abuse is associated with a dose- and time-dependent poor sperm quality and hyperprolactinaemia in young men. | Farag AGA et al. | — | 2018 | → |
| Treatment Persistence Among Insured Patients Newly Starting Buprenorphine/Naloxone for Opioid Use Disorder. | Shcherbakova N et al. | — | 2018 | → |
| Tulsa 1000: a naturalistic study protocol for multilevel assessment and outcome prediction in a large psychiatric sample. | Victor TA et al. | — | 2018 | → |
| Addressing the barriers related with opioid therapy for management of chronic pain in India. | Dureja GP et al. | — | 2017 | → |
| Association between process measures and mortality in individuals with opioid use disorders. | Watkins KE et al. | — | 2017 | → |
| Buprenorphine-naloxone treatment responses differ between young adults with heroin and prescription opioid use disorders. | Romero-Gonzalez M et al. | — | 2017 | → |
| Detection of Papaverine for the Possible Identification of Illicit Opium Cultivation. | Mirsafavi RY et al. | — | 2017 | → |
| Identifying substance misuse in primary care: TAPS Tool compared to the WHO ASSIST. | Schwartz RP et al. | — | 2017 | → |
| Impact of Mindfulness-Based Parenting on Women in Treatment for Opioid Use Disorder. | Gannon M et al. | — | 2017 | → |
| Is Admission to the Intensive Care Unit Associated With Chronic Opioid Use? A 4-Year Follow-Up of Intensive Care Unit Survivors. | Yaffe PB et al. | — | 2017 | → |
| Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. | Sordo L et al. | — | 2017 | → |
| Physician attitudes and experiences with Maryland's prescription drug monitoring program (PDMP). | Lin DH et al. | — | 2017 | → |
| Racial Differences in HIV and HCV Risk Behaviors, Transmission, and Prevention Knowledge among Non-Treatment-Seeking Individuals with Opioid Use Disorder. | Metz VE et al. | — | 2017 | → |
| Safety profile of injectable hydromorphone and diacetylmorphine for long-term severe opioid use disorder. | Oviedo-Joekes E et al. | — | 2017 | → |
| Six-Year Outcome of Opioid Maintenance Treatment in Heroin-Dependent Patients: Results from a Naturalistic Study in a Nationally Representative Sample. | Soyka M et al. | — | 2017 | → |
| Subjective effectiveness of ibogaine treatment for problematic opioid consumption: Short- and long-term outcomes and current psychological functioning. | Davis AK et al. | — | 2017 | → |
| Treatment of opioid dependence with buprenorphine: current update. | Soyka M | — | 2017 | → |
| A Prospective Study to Investigate Predictors of Relapse among Patients with Opioid Use Disorder Treated with Methadone. | Naji L et al. | — | 2016 | → |
| A Smartphone Application Supporting Recovery from Heroin Addiction: Perspectives of Patients and Providers in China, Taiwan, and the USA. | Schulte M et al. | — | 2016 | → |
| A socio-structural approach to preventing injection drug use initiation: rationale for the PRIMER study. | Werb D et al. | — | 2016 | → |
| Harm reduction for young people who use prescription opioids extra-medically: Obstacles and opportunities. | Marshall BD et al. | — | 2016 | → |
| Patterns of substance use and correlates of lifetime and active injection drug use among women in Malaysia. | Wickersham JA et al. | — | 2016 | → |
| Prescription Drug Monitoring Programs Needed to Manage Opioid Use in Asia Pacific. | Cheung CW | — | 2016 | → |
| Quality of life and its determinants for heroin addicts receiving a methadone maintenance program: Comparison with matched referents from the general population. | Lin CY et al. | — | 2016 | → |
| Readiness to change is a predictor of reduced substance use involvement: findings from a randomized controlled trial of patients attending South African emergency departments. | Myers B et al. | — | 2016 | → |
| The Future of Opioid Agonist Therapies in Ukraine: A Qualitative Assessment of Multilevel Barriers and Ways Forward to Promote Retention in Treatment. | Bojko MJ et al. | — | 2016 | → |
| The increasing global health priority of substance use in young people. | Degenhardt L et al. | — | 2016 | → |
| The pattern of substance use disorder in the United Arab Emirates in 2015: results of a National Rehabilitation Centre cohort study. | Alblooshi H et al. | — | 2016 | → |
| Treatment-refractory substance use disorder: Focus on alcohol, opioids, and cocaine. | Soyka M et al. | — | 2016 | → |
| Voltage-Gated Ion Channels in the PNS: Novel Therapies for Neuropathic Pain? | Tibbs GR et al. | — | 2016 | → |
| A heavy burden on young minds: the global burden of mental and substance use disorders in children and youth. | Erskine HE et al. | — | 2015 | → |
| Cis-Expression Quantitative Trait Loci Mapping Reveals Replicable Associations with Heroin Addiction in OPRM1. | Hancock DB et al. | — | 2015 | → |
| Drug Treatment as HIV Prevention Among Women and Girls Who Inject Drugs From a Global Perspective: Progress, Gaps, and Future Directions. | Springer SA et al. | — | 2015 | → |
| Effects of publicly funded and quality of life on attendance rate among methadone maintenance treatment patients in Taiwan: an 18-month follow-up study. | Chang KC et al. | — | 2015 | → |
| Excess mortality among opioid-using patients treated with oral naltrexone in Australia. | Degenhardt L et al. | — | 2015 | → |
| Factors associated with illicit methadone injecting in a Canadian setting. | Tucker D et al. | — | 2015 | → |
| Global Epidemiology of HIV Among Women and Girls Who Use or Inject Drugs: Current Knowledge and Limitations of Existing Data. | Larney S et al. | — | 2015 | → |
| Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. | Global Burden of Disease Study 2013 Collaborators | — | 2015 | → |
| Jurisdictional differences in opioid use, other licit and illicit drug use, and harms associated with substance use among people who tamper with pharmaceutical opioids. | Peacock A et al. | — | 2015 | → |
| Memantine improves buprenorphine/naloxone treatment for opioid dependent young adults. | Gonzalez G et al. | — | 2015 | → |
| Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial. | Rich JD et al. | — | 2015 | → |
| Molecular and neuronal plasticity mechanisms in the amygdala-prefrontal cortical circuit: implications for opiate addiction memory formation. | Rosen LG et al. | — | 2015 | → |
| Negotiating structural vulnerability following regulatory changes to a provincial methadone program in Vancouver, Canada: A qualitative study. | McNeil R et al. | — | 2015 | → |
| New developments in the management of opioid dependence: focus on sublingual buprenorphine-naloxone. | Soyka M | — | 2015 | → |
| Postmortem volumetric analysis of the nucleus accumbens in male heroin addicts: implications for deep brain stimulation. | Müller UJ et al. | — | 2015 | → |
| The CHANGE Study: Methods and Sample Description for a Cross-Sectional Study of Heroin Cessation in New York City. | Ompad DC et al. | — | 2015 | → |
| The global burden of mental, neurological and substance use disorders: an analysis from the Global Burden of Disease Study 2010. | Whiteford HA et al. | — | 2015 | → |
| The Role of Gender in Factors Associated With Addiction Treatment Satisfaction Among Long-Term Opioid Users. | Marchand K et al. | — | 2015 | → |
| Women Who Use or Inject Drugs: An Action Agenda for Women-Specific, Multilevel, and Combination HIV Prevention and Research. | El-Bassel N et al. | — | 2015 | → |
| Afghanistan has a sizeable problem with opioid use. | Hall WD et al. | — | 2014 | → |
| Commentary on Degenhardt et al. (2014): Regional variation in the global burden of disease attributable to opioid dependence-where do the data come from and does population size matter? | Hser YI et al. | — | 2014 | → |
| Response to Hser et al. (2014): The necessity for more and better data on the global epidemiology of opioid dependence. | Degenhardt L et al. | — | 2014 | → |
| The impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study. | Degenhardt L et al. | — | 2014 | → |